Protein kinases inactivating

Phosphorylation by cAMP-dependent protein kinases inactivates the reductase. This inactivation can be reversed by two specific phosphatases (Figure 25.33). 

Figure 8.8 Chemical structures of the EGRF protein kinase inactivators EKB-569 (A) and CI-1033 (B). The shaded boxes highlight the Michael acceptor group within each compound.

Src tyrosine kinase contains both an SH2 and an SH3 domain linked to a tyrosine kinase unit with a structure similar to other protein kinases. The phosphorylated form of the kinase is inactivated by binding of a phosphoty-rosine in the C-terminal tail to its own SH2 domain. In addition the linker region between the SH2 domain and the kinase is bound in a polyproline II conformation to the SH3 domain. These interactions lock regions of the active site into a nonproductive conformation. Dephosphorylation or mutation of the C-terminal tyrosine abolishes this autoinactivation. 

Smooth muscle contractions are subject to the actions of hormones and related agents. As shown in Figure 17.32, binding of the hormone epinephrine to smooth muscle receptors activates an intracellular adenylyl cyclase reaction that produces cyclic AMP (cAMP). The cAMP serves to activate a protein kinase that phosphorylates the myosin light chain kinase. The phosphorylated MLCK has a lower affinity for the Ca -calmodulin complex and thus is physiologically inactive. Reversal of this inactivation occurs via myosin light chain kinase phosphatase. 

Figure 2. Mechanism of PDH. The three different subunits of the PDH complex in the mitochondrial matrix (E, pyruvate decarboxylase E2, dihydrolipoamide acyltrans-ferase Ej, dihydrolipoamide dehydrogenase) catalyze the oxidative decarboxylation of pyruvate to acetyl-CoA and CO2. E, decarboxylates pyruvate and transfers the acetyl-group to lipoamide. Lipoamide is linked to the group of a lysine residue to E2 to form a flexible chain which rotates between the active sites of E, E2, and E3. E2 then transfers the acetyl-group from lipoamide to CoASH leaving the lipoamide in the reduced form. This in turn is oxidized by E3, which is an NAD-dependent (low potential) flavoprotein, completing the catalytic cycle. PDH activity is controlled in two ways by product inhibition by NADH and acetyl-CoA formed from pyruvate (or by P-oxidation), and by inactivation by phosphorylation of Ej by a specific ATP-de-pendent protein kinase associated with the complex, or activation by dephosphorylation by a specific phosphoprotein phosphatase. The phosphatase is activated by increases in the concentration of Ca in the matrix. The combination of insulin with its cell surface receptor activates PDH by activating the phosphatase by an unknown mechanism.

Phosphorylation of HSFl is rapid, and one or more protein kinases are likely to be activated upon HS. An alternative explanation is that heat inactivates a phosphatase which is more active than the HSF kinase at 37 °C. Inactivation of the phosphatase by heat would allow the presumptive heat stable HSF kinase activity to predominate, thus increasing the phosphorylation of HSFl. 

Both phosphorylase a and phosphorylase kinase a are dephosphorylated and inactivated by protein phos-phatase-1. Protein phosphatase-1 is inhibited by a protein, inhibitor-1, which is active only after it has been phosphorylated by cAMP-dependent protein kinase. Thus, cAMP controls both the activation and inactivation of phosphorylase (Figure 18-6). Insulin reinforces this effect by inhibiting the activation of phosphorylase b. It does this indirectly by increasing uptake of glucose, leading to increased formation of glucose 6-phosphate, which is an inhibitor of phosphorylase kinase. 

Figure 21-6. Regulation of acetyl-CoA carboxylase by phosphorylation/dephosphorylation.The enzyme is inactivated by phosphorylation by AMP-activated protein kinase (AMPK), which in turn is phosphorylated and activated by AMP-activated protein kinase kinase (AMPKK). Glucagon (and epinephrine), after increasing cAMP, activate this latter enzyme via cAMP-dependent protein kinase. The kinase kinase enzyme is also believed to be activated by acyl-CoA. Insulin activates acetyl-CoA carboxylase, probably through an "activator" protein and an insulin-stimulated protein kinase.

Draetta, G., Luca, F., Westendorf, J., Brizuela, L., Ruderman, J., and Beach, D. (1989). cdc2 protein kinase is complexed with both cyclin A and B evidence for proteolytic inactivation of MPF. Cell 56 829-836. 

Another substrate of PKB is glycogen synthase kinase 3(5 (GSK3(5), whose phosphorylation causes its inactivation. As its name indicates, this protein kinase was originally discovered as a regulator... 

LiuD, MatzukMM, Sung WK, Guo Q, WangP, Wolgemuth DJ 1998 Cyclin A1 is required for meiosis in the male mouse. Nat Genet 20 377-380 Lorca T, Cruzalequi FH, Fesquet D et al 1993 Calmodulin-dependent protein kinase II mediates inactivation of MPF and CSF activities upon fertilization of Xenopus eggs. Nature 366 270-273... 

The non-cleavage pathway would remove most cohesin during prophase/ pro-metaphase by an as yet obscure mechanism. This pathway could involve phosphorylation of a cohesin subunit by mitotic protein kinases, because vertebrate cohesins rebind to chromatin in telophase when mitotic kinases are inactivated and chromosomes decondense (Losada et al 1998). The dissociation of cohesin from chromatin during prophase coincides with, but does not depend on, the association of condensin with chromosomes. This first phase of cohesin removal may be crucial (possibly along with the arrival of... 

---